Aurinia Pharmaceuticals Inc.

NasdaqGM:AUPH Stock Report

Mkt Cap: US$1.3b

Aurinia Pharmaceuticals Company Information

Aurinia Pharmaceuticals Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Aurinia Pharmaceuticals Inc.
  • Ticker: AUPH
  • Exchange: NasdaqGM
  • Founded: NaN
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$1.332b
  • Shares outstanding: 142.11m
  • Website: https://www.auriniapharma.com

Number of Employees


Location

  • Aurinia Pharmaceuticals Inc.
  • 4464 Markham Street
  • Suite 1203
  • Victoria
  • British Columbia
  • V8Z 7X8
  • Canada


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IKAPDB (Deutsche Boerse AG)YesCommon SharesDEEURJan 1999
AUPHNasdaqGM (Nasdaq Global Market)YesCommon SharesUSUSDJan 1999
0UJFLSE (London Stock Exchange)YesCommon SharesGBCADJan 1999

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/01/28 00:00
End of Day Share Price2023/01/27 00:00
Earnings2022/09/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.